These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 33546752)

  • 1. Using ActionADE to create information continuity to reduce re-exposures to harmful medications: study protocol for a randomized controlled trial.
    Hau JP; Brasher PMA; Cragg A; Small S; Wickham M; Hohl CM
    Trials; 2021 Feb; 22(1):119. PubMed ID: 33546752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes.
    Cragg A; Small SS; Lau E; Rowe A; Lau A; Butcher K; Hohl CM
    Drug Saf; 2023 Nov; 46(11):1161-1172. PubMed ID: 37783974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing and Comparing Adverse Drug Events Documented in 2 Spontaneous Reporting Systems in the Lower Mainland of British Columbia, Canada: Retrospective Observational Study.
    Lau EY; Cragg A; Small SS; Butcher K; Hohl CM
    JMIR Hum Factors; 2024 Jan; 11():e52495. PubMed ID: 38236629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using novel Canadian resources to improve medication reconciliation at discharge: study protocol for a randomized controlled trial.
    Tamblyn R; Huang AR; Meguerditchian AN; Winslade NE; Rochefort C; Forster A; Eguale T; Buckeridge D; Jacques A; Naicker K; Reidel KE
    Trials; 2012 Aug; 13():150. PubMed ID: 22920446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of SENATOR (Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in Older peRsons) on incident adverse drug reactions (ADRs) in an older hospital cohort - Trial Protocol.
    Lavan AH; O'Mahony D; Gallagher P; Fordham R; Flanagan E; Dahly D; Byrne S; Petrovic M; Gudmundsson A; Samuelsson O; Cherubini A; J Cruz-Jentoft A; Soiza RL; Eustace JA
    BMC Geriatr; 2019 Feb; 19(1):40. PubMed ID: 30760204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a computerized drug-monitoring program to detect and prevent adverse drug events and medication non-adherence in outpatient ambulatory care: study protocol of a randomized controlled trial.
    Forster AJ; Erlanger TE; Jennings A; Auger C; Buckeridge D; van Walraven C; Tamblyn R
    Trials; 2015 Jan; 16():2. PubMed ID: 25572800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving quality of care and long-term health outcomes through continuity of care with the use of an electronic or paper patient-held portable health file (COMMUNICATE): study protocol for a randomized controlled trial.
    Lassere MN; Baker S; Parle A; Sara A; Johnson KR
    Trials; 2015 Jun; 16():253. PubMed ID: 26040644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods Design.
    Peddie D; Small SS; Badke K; Wickham ME; Bailey C; Chruscicki A; Ackerley C; Balka E; Hohl CM
    JMIR Res Protoc; 2016 Aug; 5(3):e169. PubMed ID: 27538362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
    Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Blumberg HM; Marconi VC
    Trials; 2020 May; 21(1):383. PubMed ID: 32370774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial.
    Stingl JC; Kaumanns KL; Claus K; Lehmann ML; Kastenmüller K; Bleckwenn M; Hartmann G; Steffens M; Wirtz D; Leuchs AK; Benda N; Meier F; Schöffski O; Holdenrieder S; Coch C; Weckbecker K
    BMC Fam Pract; 2016 Apr; 17():49. PubMed ID: 27112273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat adverse drug events associated with outpatient medications: a descriptive analysis of 3 observational studies in British Columbia, Canada.
    Hohl CM; Woo SA; Cragg A; Wickham ME; Ackerley C; Scheuermeyer F; Villanyi D
    CMAJ Open; 2019; 7(3):E446-E453. PubMed ID: 31320328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a medico-pharmaceutical follow-up and an optimized communication between hospital and community on the readmission to the emergency department for an adverse drug event: URGEIM, study protocol for a randomized controlled trial.
    Breuker C; Faucanié M; Laureau M; Perier D; Pinzani V; Marin G; Sebbane M; Villiet M
    Trials; 2021 Aug; 22(1):521. PubMed ID: 34362410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the Novel Uses of adaptive Designs to Guide provider Engagement in Electronic Health Records (NUDGE-EHR) pragmatic adaptive randomized trial: a trial protocol.
    Lauffenburger JC; Isaac T; Trippa L; Keller P; Robertson T; Glynn RJ; Sequist TD; Kim DH; Fontanet CP; Castonguay EWB; Haff N; Barlev RA; Mahesri M; Gopalakrishnan C; Choudhry NK
    Implement Sci; 2021 Jan; 16(1):9. PubMed ID: 33413494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An external facilitation intervention to increase uptake of an adverse drug event reporting intervention.
    Lau EY; Small SS; Butcher K; Cragg A; Loh GW; Shalansky S; Hohl CM
    Front Health Serv; 2023; 3():1106586. PubMed ID: 37332530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial.
    De Vera MA; Sadatsafavi M; Tsao NW; Lynd LD; Lester R; Gastonguay L; Galo J; FitzGerald JM; Brasher P; Marra CA
    Trials; 2014 Dec; 15():488. PubMed ID: 25494702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEDUCATE trial: effectiveness of an intensive EDUCATional intervention for IT-mediated MEDication management in the outpatient clinic - study protocol for a cluster randomized controlled trial.
    van Stiphout F; Zwart-van Rijkom JE; Aarts JE; Koffijberg H; Klarenbeek-deJonge E; Krulder M; Roes KC; Egberts AC; ter Braak EW
    Trials; 2015 May; 16():223. PubMed ID: 25997633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a tailored health information technology- driven intervention to improve health literacy and medication adherence in a Pakistani population with vascular disease (Talking Rx) - study protocol for a randomized controlled trial.
    Kamal AK; Muqeet A; Farhat K; Khalid W; Jamil A; Gowani A; Muhammad AA; Zaidi F; Khan D; Elahi T; Sharif S; Raz S; Zafar T; Bokhari SS; Rahman N; Sultan FA; Sayani S; Virani SS
    Trials; 2016 Mar; 17(1):121. PubMed ID: 26944938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial.
    Maddison R; Stewart R; Doughty R; Scott T; Kerr A; Benatar J; Whittaker R; Rawstorn JC; Rolleston A; Jiang Y; Estabrooks P; Sullivan RK; Bartley H; Pfaeffli Dale L
    Trials; 2018 Jan; 19(1):70. PubMed ID: 29370829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of collaborative pharmaceutical care on in-patients' medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study).
    Leguelinel-Blache G; Castelli C; Roux-Marson C; Bouvet S; Andrieu S; Cestac P; Collomp R; Landais P; Loulière B; Mouchoux C; Varin R; Allenet B; ; Bedouch P; Kinowski JM
    Trials; 2018 Jan; 19(1):19. PubMed ID: 29310711
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.